신종 코로나바이러스 특집 콘텐츠

이 페이지는 다른 언어로도 제공됩니다: English 日本語简体中文繁體中文

코로나 바이러스, 2020. David S. Goodsell @ RCSB PDB에 의한 오리지널 일러스트를 수정

신종 코로나바이러스 감염증 (Novel Coronavirus disease 2019:COVID-19)의 확산이 세계적으로 매우 큰 문제가 되고 있습니다. 시급히 새로운 바이러스（Severe Acute Respiratory Syndrome Coronavirus 2: SARS-CoV-2）를 이해하고 효과적인 약을 개발하기 위해, 신속하게 구조 생물학 연구가 시작되고 있습니다. PDBj는 사용자의 편의를 도모하기 위해 신종 코로나바이러스의 특집 페이지를 제공하고 있습니다. 매주 수요일에 최신 항목이 추가됩니다.

바이러스 단백질에 관한 해설기사는 아래의 「이달의 분자」 페이지를 참조하십시오.

「전체 엔트리」 탭에는, 모든 PDB ID가 포함되어 있습니다. 이용자가 전체의 독립된 엔트리를 검색하고 싶을 때 사용하실 수 있으며, 동일 저자에 의한 그룹등록의 엔트리도 전부 구별되어 있습니다. 「대표구조」 탭에는, 분해능이 가장 높은 대표구조만을 표지하고 있습니다. 아미노산 서열이 100 % 일치하는 PDB 엔트리의 경우, 다른 리간드를 포함하여도 대표구조에는 제외됩니다. 「최신 엔트리」 탭은, 이번주 공개된 가장 최근의 엔트리 입니다.

Created: 2020-09-03 (last edited: more than 1 year ago)

전체 엔트리 (5197)대표구조 (2266)최신 엔트리 (44)

9BS8

Structure of the SARS-CoV-2 main protease in complex with inhibitor YR-B-107
Descriptor:	3C-like proteinase nsp5, benzyl (7S)-7-({(2R)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6-azaspiro[3.4]octane-6-carboxylate
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSA

Structure of the SARS-CoV-2 main protease in complex with inhibitor VB-B-112
Descriptor:	2,2-dichloro-N-(5-chloropyridin-3-yl)-N-phenylacetamide, 3C-like proteinase nsp5
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSE

Structure of the SARS-CoV-2 main protease in complex with inhibitor YR-B-165
Descriptor:	(3S)-N-{(2S)-1-amino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-2-[(2R)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-2-azaspiro[4.5]decane-3-carboxamide, 3C-like proteinase nsp5
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.85 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSF

Structure of the SARS-CoV-2 main protease in complex with inhibitor SR-A-171
Descriptor:	3C-like proteinase nsp5, N-(4-tert-butylphenyl)-2,2-dichloro-N-(5-chloropyridin-3-yl)acetamide
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.75 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSG

Structure of the SARS-CoV-2 main protease in complex with inhibitor VB-C-20
Descriptor:	3C-like proteinase nsp5, methyl 4-[(5-chloropyridin-3-yl)(phenyl)amino]-4-oxobutanoate
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.75 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSI

Structure of the SARS-CoV-2 main protease in complex with inhibitor SR-B-7
Descriptor:	3C-like proteinase nsp5, N-[(1M)-3'-chloro[1,1'-biphenyl]-3-yl]-N-(5-chloropyridin-3-yl)-2-fluoroacetamide
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSO

Structure of the SARS-CoV-2 main protease in complex with inhibitor SR-B-13
Descriptor:	3C-like proteinase nsp5, N-[(1M)-3'-chloro[1,1'-biphenyl]-3-yl]-N-(5-chloropyridin-3-yl)-3-sulfanylpropanamide
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSP

Structure of the SARS-CoV-2 main protease in complex with inhibitor VB-C-68
Descriptor:	3C-like proteinase nsp5, methyl 4-{[(1M)-3'-chloro[1,1'-biphenyl]-3-yl](5-chloropyridin-3-yl)amino}-4-oxobutanoate
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.6 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSQ

Structure of the SARS-CoV-2 main protease in complex with inhibitor VB-C-70
Descriptor:	(2R)-N-[(1M)-3'-chloro[1,1'-biphenyl]-3-yl]-N-(5-chloropyridin-3-yl)-2-hydroxy-2-sulfanylacetamide, 3C-like proteinase nsp5
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BSR

Structure of the SARS-CoV-2 main protease in complex with inhibitor YR-B-136B
Descriptor:	(1R,2S,5R)-N-[(1R)-1-(7-fluoroisoquinolin-4-yl)-2-iminoethyl]-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide, 3C-like proteinase nsp5
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9BST

Structure of the SARS-CoV-2 main protease in complex with inhibitor CID8009_5647
Descriptor:	3C-like proteinase nsp5, [3-[2,6-bis(chloranyl)phenyl]-5-methyl-1,2-oxazol-4-yl]methanol
Authors:	Blankenship, L.R, Liu, W.R.
Deposit date:	2024-05-13
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.6 Å)
Cite:	Structure of the SARS-CoV-2 main protease To Be Published

9C2H

SARS-CoV-2 Nucleocapsid Dimerization Domain bound to Fab-NP1E9 and Fab-NP3B4
Descriptor:	Antibody Fab NP1-E9 Heavy Chain (variable region), Antibody Fab NP1-E9 Light Chain (variable region), Antibody Fab NP3-B4 Heavy Chain (variable region), ...
Authors:	Landeras-Bueno, S, Hariharan, C, Diaz Avalos, R, Ollmann Saphire, E.
Deposit date:	2024-05-31
Release date:	2025-05-14
Method:	ELECTRON MICROSCOPY (3.7 Å)
Cite:	Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome To Be Published

9F7P

SARS-CoV-2 papain-like protease (PLpro) C112S mutant
Descriptor:	CHLORIDE ION, DI(HYDROXYETHYL)ETHER, MALONATE ION, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-04
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.7 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S mutant To Be Published

9F7Q

SARS-CoV-2 papain-like protease (PLpro) C112S mutant
Descriptor:	GLYCEROL, Replicase polyprotein 1ab, SULFATE ION, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-04
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S mutant To Be Published

9F7R

SARS-CoV-2 papain-like protease (PLpro) C112S mutant
Descriptor:	GLYCEROL, PHOSPHATE ION, Replicase polyprotein 1ab, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-04
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S mutant To Be Published

9F7S

SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-K229R mutant
Descriptor:	CHLORIDE ION, DI(HYDROXYETHYL)ETHER, MALONATE ION, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-04
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-K229R mutant To Be Published

9F7T

SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-K229R mutant: dimer
Descriptor:	CHLORIDE ION, DI(HYDROXYETHYL)ETHER, Replicase polyprotein 1ab, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-04
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (2.05 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-K229R mutant To Be Published

9F7U

SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-Q222D-K229R-Q230R-C271S mutant
Descriptor:	CHLORIDE ION, GLYCEROL, MALONIC ACID, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-05
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.6 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-Q222D-K229R-Q230R-C271S mutant To Be Published

9F7Y

SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-Q222D-K229R-Q230R-C271S mutant
Descriptor:	CHLORIDE ION, MALONIC ACID, Replicase polyprotein 1ab, ...
Authors:	Camara-Artigas, A.
Deposit date:	2024-05-05
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.8 Å)
Cite:	SARS-CoV-2 papain-like protease (PLpro) C112S-K191D-Q222D-K229R-Q230R-C271S mutant To Be Published

9LVR

Crystal structure of SARS-CoV-2 3CL protease in complex with compound 1
Descriptor:	1,2-ETHANEDIOL, 3C-like proteinase nsp5, 6-(1,3-dihydroisoindol-2-yl)-3-(5-methylpyridin-3-yl)-1-[[3,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione
Authors:	Unoh, Y, Hirai, K, Uehara, S, Kawashima, S, Nobori, H, Sato, J, Shibayama, H, Hori, A, Nakahara, K, Kurahashi, K, Takamatsu, M, Yamamoto, S, Zhang, O, Tanimura, M, Dodo, R, Maruyama, Y, Sawa, H, Watari, R, Miyano, T, Kato, T, Sato, T, Tachibana, Y.
Deposit date:	2025-02-12
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (2.2 Å)
Cite:	Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 To Be Published

9LVT

Crystal structure of SARS-CoV-2 3CL protease in complex with compound 4
Descriptor:	1-(2-azanylideneethyl)-6-(1,3-dihydroisoindol-2-yl)-3-(5-methylpyridin-3-yl)-5-[[3,4,5-tris(fluoranyl)phenyl]methyl]pyrimidine-2,4-dione, 3C-like proteinase
Authors:	Unoh, Y, Hirai, K, Uehara, S, Kawashima, S, Nobori, H, Sato, J, Shibayama, H, Hori, A, Nakahara, K, Kurahashi, K, Takamatsu, M, Yamamoto, S, Zhang, O, Tanimura, M, Dodo, R, Maruyama, Y, Sawa, H, Watari, R, Miyano, T, Kato, T, Sato, T, Tachibana, Y.
Deposit date:	2025-02-12
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 To Be Published

9LVV

Crystal structure of SARS-CoV-2 3CL protease in complex with compound 17 (S-892216)
Descriptor:	1-(2-azanylideneethyl)-6-[6,6-bis(fluoranyl)-2-azaspiro[3.3]heptan-2-yl]-5-(3-chloranyl-4-fluoranyl-phenyl)-3-(5-chloranylpyridin-3-yl)pyrimidine-2,4-dione, 3C-like proteinase
Authors:	Unoh, Y, Hirai, K, Uehara, S, Kawashima, S, Nobori, H, Sato, J, Shibayama, H, Hori, A, Nakahara, K, Kurahashi, K, Takamatsu, M, Yamamoto, S, Zhang, O, Tanimura, M, Dodo, R, Maruyama, Y, Sawa, H, Watari, R, Miyano, T, Kato, T, Sato, T, Tachibana, Y.
Deposit date:	2025-02-12
Release date:	2025-05-14
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19 To Be Published

7I13

PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B05 from the F2X-Entry Screen in orthorhombic space group
Descriptor:	2-acetylbenzoic acid, 3C-like proteinase nsp5, CHLORIDE ION, ...
Authors:	Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S.
Deposit date:	2025-02-03
Release date:	2025-05-21
Method:	X-RAY DIFFRACTION (2 Å)
Cite:	Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening To be published

7I14

PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment B08 from the F2X-Entry Screen in orthorhombic space group
Descriptor:	3C-like proteinase nsp5, DIMETHYL SULFOXIDE, ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate
Authors:	Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S.
Deposit date:	2025-02-03
Release date:	2025-05-21
Method:	X-RAY DIFFRACTION (1.95 Å)
Cite:	Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening To be published

7I15

PanDDA analysis group deposition -- Main Protease (SARS-CoV-2) in complex with fragment C02 from the F2X-Entry Screen in orthorhombic space group
Descriptor:	2,4,5-tris(fluoranyl)-3-methoxy-benzoic acid, 3C-like proteinase nsp5, CHLORIDE ION, ...
Authors:	Barthel, T, Benz, L.S, Wollenhaupt, J, Weiss, M.S.
Deposit date:	2025-02-03
Release date:	2025-05-21
Method:	X-RAY DIFFRACTION (2 Å)
Cite:	Orthorhombic SARS-CoV-2 main protease crystals provide higher success rate in fragment screening To be published

<190 191 192 193 194 195 196197198 199 200 201 202 203 204 205 >

Total results:	5197
Displayed results:	25
Sorted by:	Release date (from oldest)